4//SEC Filing
Nolte Alexander 4
Accession 0001562180-22-001077
CIK 0001395937other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:31 PM ET
Size
8.7 KB
Accession
0001562180-22-001077
Insider Transaction Report
Form 4
Nolte Alexander
Chief Accounting Officer
Transactions
- Other
Common Stock
2022-01-31$12.39/sh+968$11,994→ 968 total - Sale
Common Stock
2022-02-01$16.65/sh−968$16,117→ 0 total - Award
Stock Options (Right to buy)
2022-02-02$15.79/sh+30,000$473,700→ 30,000 totalExercise: $15.79Exp: 2032-02-02→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 968 shares by the Reporting Person on 01/31/2022 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]1/48th of the shares subject to the option shall vest monthly over a four-year period.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001891979
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:31 PM ET
- Size
- 8.7 KB